Arm | S. mansoni prevalence (% and 95% CI) | S. haematobium prevalence (%) | ||||||
---|---|---|---|---|---|---|---|---|
Survey | KK | P-value | POC-CCA+ | P-value | POC-CCA− | P-value | Urine filtration | |
Arm 1 pilot | Baseline | 0.4 (0.06,1.4) | 0.54 | 7.1 (5.2, 9.7) | 0.09* | 2.7 (1.6, 4.6) | 0.5 | 0 |
FU1 | 2.7 (1.6, 4.6) | 14.8 (12.1, 18.1) | 9.1 (7, 11.9) | 0 | ||||
FU2 | 0.18 (0, 1.2) | 14.5 (11.7, 17.8) | 6.5 (4.8, 9) | 0 | ||||
FU3 | 0.17 (0,008, 1.1) | 9.9 (7.7, 12.7) | 3.4 (2.5, 5.3) | 0.3 | ||||
Arm 1a | Baseline | 0.8 (0.4, 1.5) | 0.2 | 23.2 (21, 25.5) | < 0.0001* | 11.2 (9.7, 13.1) | < 0.0001* | 0.1 |
FU1 | 0 | 18.1 (16.3, 20.1) | 5.4 (4.4, 6.7) | 0 | ||||
FU2 | 0.4 (0.2, 0.9) | 11.3 (9.8, 13) | 7.8 (6.6, 9.3) | 0.06 | ||||
Arm 2b | Baseline | 3.6 (2.8, 4.5) | < 0.0001* | 20.2 (18.5, 22) | < 0.0001* | 15.5 (14, 17.1) | < 0.0001* | 0 |
FU1 | 1.9 (1.4, 2.6) | 12.6 (11.2, 14.1) | 6.9 (5.9, 8.1) | 0 | ||||
FU2 | 0.6 (0.3, 1) | 12.5 (11.1, 14) | 8.1 (7, 9.3) | 0 | ||||
Arm 3c | Baseline | 0.4 (0.17, 0.75) | 0.12 | 31.6 (26.7, 33.6) | < 0.0001* | 17.7 (16.1, 19.4) | 0.05 | 0.09 |
FU1 | 0.13 (0.03, 0.4) | 20 (18.4, 21.8) | 15.5 (14.1, 17.1) | 0 |